Suchergebnisse - "Vermeire, S"

PubPharm (8)

1

Dose de-escalation to adalimumab 40 mg every 3 weeks in patients with Crohn's disease - a nested case-control study

enthalten in: Alimentary pharmacology & therapeutics | 2017

von Van Steenbergen, S. | Bian, S. | Vermeire, S. | +3

CommentIn: Aliment Pharmacol Ther. 2017 May;45(9):1265-1266. - PMID 28370052

2

Postoperative Inflammatory Response in Crohn's Patients : A Comparative Study

enthalten in: Journal of Crohn's & colitis | 2015

von de Buck van Overstraeten, A. | Van Hoef, S. | Vermeire, S. | +5

3

Randomised clinical trial : vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's disease

enthalten in: Alimentary pharmacology & therapeutics | 2015

von Feagan, B. | Sandborn, W. | D'Haens, G. | +10

CommentIn: Aliment Pharmacol Ther. 2016 Aug;44(3):307-8. - PMID 27375100

4

Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients

enthalten in: Journal of Crohn's & colitis | 2013

von Baert, F. | Glorieus, E. | Reenaers, C. | +57

5

Predicting relapse in Crohn's disease : a biopsychosocial model

enthalten in: Gut | 2008

von Bitton, A. | Dobkin, P. | Edwardes, M. | +8

CommentIn: Gut. 2008 Oct;57(10):1345-7. - PMID 18791113

6

Laboratory markers in IBD : useful, magic, or unnecessary toys?

enthalten in: Gut | 2006

von Vermeire, S. | Van Assche, G. | Rutgeerts, P.

7

Tumour necrosis factor-alpha receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab

enthalten in: Alimentary pharmacology & therapeutics | 2004

von Pierik, M. | Vermeire, S. | Steen, K. | +4

8

A positive response to infliximab in Crohn disease : association with a higher systemic inflammation before treatment but not with -308 TNF gene polymorphism

enthalten in: Scandinavian journal of gastroenterology | 2002

von Louis, E. | Vermeire, S. | Rutgeerts, P. | +9

1
[1]